ATE299374T1 - Adenosine als antithrombosemittel - Google Patents

Adenosine als antithrombosemittel

Info

Publication number
ATE299374T1
ATE299374T1 AT01112092T AT01112092T ATE299374T1 AT E299374 T1 ATE299374 T1 AT E299374T1 AT 01112092 T AT01112092 T AT 01112092T AT 01112092 T AT01112092 T AT 01112092T AT E299374 T1 ATE299374 T1 AT E299374T1
Authority
AT
Austria
Prior art keywords
biologically active
extract
plant
novel method
active ingredients
Prior art date
Application number
AT01112092T
Other languages
English (en)
Inventor
Su-Chen Chang
Li-Wei Hsu
Original Assignee
Advanced Gene Technology Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Gene Technology Corp filed Critical Advanced Gene Technology Corp
Application granted granted Critical
Publication of ATE299374T1 publication Critical patent/ATE299374T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70546—Integrin superfamily, e.g. VLAs, leuCAM, GPIIb/GPIIIa, LPAM
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT01112092T 2000-11-07 2001-05-29 Adenosine als antithrombosemittel ATE299374T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US70830600A 2000-11-07 2000-11-07

Publications (1)

Publication Number Publication Date
ATE299374T1 true ATE299374T1 (de) 2005-07-15

Family

ID=24845266

Family Applications (2)

Application Number Title Priority Date Filing Date
AT01110765T ATE299593T1 (de) 2000-11-07 2001-05-03 Verfahren zum screenen von pflanzenextrakten nach wirkstoffen
AT01112092T ATE299374T1 (de) 2000-11-07 2001-05-29 Adenosine als antithrombosemittel

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT01110765T ATE299593T1 (de) 2000-11-07 2001-05-03 Verfahren zum screenen von pflanzenextrakten nach wirkstoffen

Country Status (7)

Country Link
US (1) US20020082241A1 (de)
EP (2) EP1205754B1 (de)
CN (2) CN1352945A (de)
AT (2) ATE299593T1 (de)
AU (1) AU5178801A (de)
CA (1) CA2348845A1 (de)
DE (2) DE60111906D1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6855343B2 (en) * 2002-05-21 2005-02-15 Advanced Gene Technology, Corp Method to ascertain the quality of herbs
CN106501415A (zh) * 2016-12-02 2017-03-15 丽珠集团丽珠制药厂 一种阿魏酸钠、阿司匹林、桂利嗪和维生素b1的含量测定方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5770198A (en) * 1988-05-18 1998-06-23 The Research Foundation Of The State Of New York Platelet-specific chimeric 7E3 immunoglobulin
CA2073696A1 (en) * 1990-02-02 1991-08-03 Peter L. Barker Cyclic peptides containing arg-gly-asp flanked by proline
US5677290A (en) * 1990-05-10 1997-10-14 Fukunaga; Atsuo F. Therapeutic use of adenosine compounds as surgical anesthetics
JP3002903B2 (ja) * 1991-04-09 2000-01-24 第一化学薬品株式会社 血管外血液の抗凝固・抗血小板剤組成物及びこれを用いる血小板活性化の分子マーカーの測定法
US6137002A (en) * 1993-07-22 2000-10-24 Eli Lilly And Company Glycoprotein IIb/IIIa antagonists
IL121272A (en) * 1997-07-10 2000-06-01 Can Fite Technologies Ltd Pharmaceutical compositions comprising adenosine and their use for treating or preventing leukopenia
DE19802576B4 (de) * 1998-01-23 2004-10-28 Xerion Pharmaceuticals Ag Verfahren zur gleichzeitigen Identifizierung von Proteinen und ihren Bindungspartnern
US6713309B1 (en) * 1999-07-30 2004-03-30 Large Scale Proteomics Corporation Microarrays and their manufacture

Also Published As

Publication number Publication date
EP1205754A3 (de) 2002-07-17
EP1205182B1 (de) 2005-07-13
DE60111905D1 (de) 2005-08-18
EP1205182A2 (de) 2002-05-15
CN1220060C (zh) 2005-09-21
EP1205182A3 (de) 2002-09-04
CN1353003A (zh) 2002-06-12
CN1352945A (zh) 2002-06-12
US20020082241A1 (en) 2002-06-27
EP1205754A2 (de) 2002-05-15
CA2348845A1 (en) 2002-05-07
AU5178801A (en) 2002-05-09
DE60111906D1 (de) 2005-08-18
ATE299593T1 (de) 2005-07-15
EP1205754B1 (de) 2005-07-13

Similar Documents

Publication Publication Date Title
IS2508B (is) Mótefni gegn ED-B hneppinu í fíbrónektíni, smíði þeirra og notkanir
ATE340870T1 (de) Adressierbare protein arrays
MEP32608A (en) Antibodies to opgl
ATE425989T1 (de) Proteinreinigungsverfahren
FI875732A (fi) Elektrokemoluminescens- analysfoerfaranden.
BR9910332A (pt) Polipeptìdio, composição, método para purificação de polipeptìdio a partir de uma composição e método para purificação de um anticorpo a partir de uma composição
BRPI0407397A (pt) Evento de algodão mon 88913 e composições e métodos para sua detecção
DK0943097T3 (da) Fremgangsmåde til at påvise IgE
ATE394673T1 (de) Selbstanordnende moleküle
DE60133479D1 (de) Modifizierter tpo-agonisten antikörper
DE69610716D1 (de) Topiramate-immunoassay, sowie analoge und antikörper
BR9407422A (pt) Kit de ensaio
DE60043944D1 (de) Zytokin zcyt018
DK1238284T3 (da) Diagnostisk bestemmelse af slagtilfælde
CN103900893A (zh) 富集乙酰化修饰的蛋白质的试剂盒及方法和应用
ATE299374T1 (de) Adenosine als antithrombosemittel
AU5406800A (en) Method for carrying out the chromatographic fractionation of plasma or serum, preparations obtained thereby and their use
ES2195033T3 (es) Iso-indolonas condensadas utilizadas como inhibidores de proteina quinasa c.
Accomazzo et al. Bell-shaped curves for prostaglandin-induced modulation of adenylate cyclase: two mutually opposing effects
EP1732880A4 (de) Assays für amphetamin und methamphetamin
Legrand et al. Two structural types of ciguatoxins involved on ciguatera fish poisoning in French Polynesia
Hakki et al. A 56 kDa binding protein for Escherichia coli heat-stable enterotoxin isolated from the cytoskeleton of rat intestinal membranes does not possess guanylate cyclase activity
DK1161522T3 (da) Fremgangsmåde til isolering af CD8+-celler og beslægtede hybridomaceller, antistoffer og polypeptider
Jackson et al. Protein Techniques: Immunoprecipitation, In Vitro Kinase Assays, and Western Blotting
ATE251305T1 (de) Immunoisolierung von caveolae

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties